Frontlight ResearchEarly access
CompletedNo phase
Effectiveness and Safety of Pharmacopuncture Therapy for Patients with Lumbar Spinal Stenosis
Key facts
- Who runs it
- Jaseng Medical Foundation
- Where
- South Korea7 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 98 people enrolled
- Started
- 13 Apr 2022
- Ended
- 28 Oct 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- pharmacopuncture
- conservative treatments (including physiotherapy)
- Record updated
- 9 January 2025
Who can take part
- Age
- 19 years to 69 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (17)Hide the full registry criteria
Who can take part
- Diagnosed with lumbar spinal stenosis based on radiology including computed tomography or magnetic resonance imaging
- Clear neurogenic claudication symptoms existed (symptoms aggravated with walking, and alleviated upon resting in lumbar flexion position)
- reported radiating leg pain or low back pain (LBP) with intensity of NRS ≥5
- Between the age of 19 and 69 years old
- Participants who agreed to participate the study and voluntarily signed the informed consent form
Who cannot take part
- Patients who administrate those prescribed medicine that may interfere with interpretation of the result (e.g. corticosteroids, immunosuppressants, physchotropic drugs)
- Patients who were treated with one of the following intervention within the past week; medicine that may potentially influence pain such as NSAIDs (nonsteroidal antiinflammatory drugs), pharmacopuncture, or physical therapies
- Previous participation in other clinical studies within 1 month of current study enrollment, or plans to participate in other clinical studies during participation (including follow-up period) of the current study after study enrollment
- Patients with other systemic diseases that may interfere with treatment effect or outcome interpretation
- Patients for whom pharmacopuncture treatment may be inappropriate or unsafe (e.g. hemorrhagic diseases, blood clotting disorders, history of anti-coagulation medicine intake, serious diabetes with risk of infection)
- Patients with medical history of spinal surgery within the past 3 months
- Patients with vascular claudication
- Patients with pathologies of non-spinal origin that may cause LBP or radiating leg pain (e.g. spinal tumor, fracture)
- Patients with soft tissue pathologies that may cause LBP or radiating leg pain (e.g. tumor, fibromyalgia, rheumatoid arthritis, gout)
- Pregnant patients or patients planning pregnancy
- Patients unable to fill out study participation consent form
- Patients deemed unsuitable for study participation as assessed by the researchers
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is 1:1 pragmatic randomized controlled trials in a parallel-grouped, multi-centered design that investigated pharmacopuncture therapy for patients with lumbar spinal stenosis, compared to the conservative treatments including physiotherapy and pharmacological treatments.
The 2 groups in the trial
- pharmacopuncture groupTreatment being tested
The physicians will choose the type and volume of pharmacopuncture according to participants' conditions.
Treatment: pharmacopuncture
- conservative treatment groupExisting treatment, for comparison
The physicians will choose the type and time of physical therapy and if needed, pharmacological treatment according to participants' conditions.
Treatment: conservative treatments (including physiotherapy)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effectiveness and Safety of Pharmacopuncture Therapy for Patients with Lumbar Spinal Stenosis : Multicentered, Pragmatic Randomized Controlled, Parallel Grouped Study
- Publications
- Pharmacopuncture therapy versus usual care for lumbar spinal stenosis: A randomized controlled trial.Integrative medicine research, 2026
- The Effectiveness of Pharmacopuncture in Patients with Lumbar Spinal Stenosis: A Protocol for a Multi-Centered, Pragmatic, Randomized, Controlled, Parallel Group Study.Journal of pain research, 2022
- Record updated
- 9 January 2025